Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
83.8 USD | +1.16% | +3.58% | +8.61% |
Financials (USD)
Sales 2024 * | 1.16B | Sales 2025 * | 1.25B | Capitalization | 13.21B |
---|---|---|---|---|---|
Net income 2024 * | 180M | Net income 2025 * | 225M | EV / Sales 2024 * | 11.5 x |
Net Debt 2024 * | 178M | Net cash position 2025 * | 16.78M | EV / Sales 2025 * | 10.6 x |
P/E ratio 2024 * |
75
x | P/E ratio 2025 * |
60.1
x | Employees | 3,050 |
Yield 2024 * |
0.38% | Yield 2025 * |
0.38% | Free-Float | 99.03% |
Latest transcript on Bio-Techne Corporation
1 day | +1.16% | ||
1 week | +3.58% | ||
Current month | +32.58% | ||
1 month | +33.60% | ||
3 months | +17.03% | ||
6 months | +37.27% | ||
Current year | +8.61% |
Managers | Title | Age | Since |
---|---|---|---|
Kim Kelderman
CEO | Chief Executive Officer | 57 | 18-04-29 |
James Hippel
DFI | Director of Finance/CFO | 53 | 14-03-31 |
Matthew McManus
COO | Chief Operating Officer | 55 | Jan. 07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 02-12-31 | |
Randolph Steer
BRD | Director/Board Member | 74 | 89-12-31 |
Joseph Keegan
BRD | Director/Board Member | 71 | 17-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.93% | 1 M€ | +0.15% | - | |
2.50% | 5 M€ | -1.80% | - | |
2.15% | 2 M€ | -.--% | ||
1.25% | 0 M€ | 0.00% | - | |
1.13% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 83.8 | +1.16% | 1,379,971 |
24-05-16 | 82.84 | -0.79% | 1,389,946 |
24-05-15 | 83.5 | -0.77% | 1,149,196 |
24-05-14 | 84.15 | +2.66% | 926,909 |
24-05-13 | 81.97 | +1.31% | 1,418,015 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.61% | 13.21B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B | |
+2.05% | 10.14B |
- Stock Market
- Equities
- TECH Stock